Sarcopenia And Regional Adiposity In Cardiac Amyloidosis

Joshua Longinow,Saeid Mirzai,Po-Hao Chen,Mazen Hanna,Wai Hong Tang
DOI: https://doi.org/10.1016/j.cardfail.2023.10.025
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Background Sarcopenia is associated with worse outcomes in patients with chronic heart failure (HF). In chronic HF from cardiac amyloid (CA), malnutrition, frailty, and exercise capacity are important prognostic factors. Hypothesis Loss of muscle mass and low subcutaneous adipose tissue are associated with poor prognosis in patients with CA. Methods We identified consecutive patients between January 2001 and August 2021 with CA, either transthyretin (ATTR) or light-chain (AL), who had chest computed tomography (CT) within one year before the date of diagnosis. Chest CT scans were used to measure chest circumference and quantify skeletal muscle index (SMI) and subcutaneous adipose tissue index (SATI) at the T12 vertebral level. Sarcopenia was defined as the lowest sex-stratified SMI tertile, and higher SATI was the highest sex-stratified SATI tertile. Results A total of 160 patients with either ATTR- or AL-CA were identified. Of these, 33% (N=53) were deemed sarcopenic. Adjusted for age, the presence of sarcopenia predicted worse survival in CA (Figure 1A). Higher SMI (cm2/m2; HR 0.96, CI 0.93-0.98, P=0.008) and larger chest circumference (mm; HR 0.98, CI 0.96-0.99, P=0.04) independently predicted better survival in CA. Adjusted for age, those with CA and higher SATI had better survival than those with CA and lower SATI (Figure 1B; HR 0.62, CI 0.40-0.95, P=0.03). On subgroup analysis, ATTR-CA with higher SATI had better overall survival and fewer hospitalizations than ATTR-CA with lower SATI; this did not apply to patients with AL-CA divided based on SATI. Conclusion When adjusted for age, sarcopenia predicted worse survival in CA. Furthermore, higher SMI and larger chest circumference were independent predictors of better survival. Patients with higher SATI had better survival which remained significant on subgroup analysis of patients with ATTR-CA but not AL-CA.
cardiac & cardiovascular systems
What problem does this paper attempt to address?